Mycobacterium tuberculosis antigens — Drug Target

All drugs that target Mycobacterium tuberculosis antigens — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Therapeutic vaccine

Phase 3 pipeline (1)

• GamTBvac · Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation · Therapeutic vaccine · Infectious Disease / Immunology
  GamTBvac is a therapeutic tuberculosis vaccine that stimulates immune responses against Mycobacterium tuberculosis antigens to enhance host immunity and control infection.